TY - JOUR
T1 - Tau pathology
T2 - Predictive diagnostics, targeted preventive and personalized medicine and application of advanced research in medical practice
AU - Gozes, Illana
N1 - Funding Information:
I serve as the Chief Scientific Officer of Allon Therapeutics Inc. ( www.allontherapeutics.com ) and I am grateful to the Allon Therapeutics team for valuable input. Studies were supported in part by Allon Therapeutics Inc. and A.M.N Foundation.
PY - 2010/6
Y1 - 2010/6
N2 - Microtubules are key cytoskeletal elements found in all eukaryotic cells. The microtubule shaft is composed of the heterodimer protein, tubulin and decorated with multiple microtubule associated protein, regulating microtubule function. Tau (tubulin associated unit) or MAPT (microtubule associated protein tau), among the first microtubule associated proteins to be identified, was implicated in microtubule initiation as well as assembly, with increased expression in neurons and specific association with axonal microtubules. Alzheimer's disease (AD) is the most prevalent tauopathy, exhibiting tau-neurofibrillary tangles associated with cognitive dysfunction. AD is also characterized by β-amyloid plaques. An abundance of tau inclusions, in the absence of β-amyloid deposits, can be found in Pick's disease, progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and other diseases, collectively described as tauopathies. The increase in tau pathology in AD correlates with the associated cognitive decline. The current manuscript touches on the variability as well as common denominators of the various tau pathologies coupled to new approaches/current innovation in treatment of tauopathies in favor of advanced technologies in predictive diagnostics, targeted preventive and personalized medicine (PPPM).
AB - Microtubules are key cytoskeletal elements found in all eukaryotic cells. The microtubule shaft is composed of the heterodimer protein, tubulin and decorated with multiple microtubule associated protein, regulating microtubule function. Tau (tubulin associated unit) or MAPT (microtubule associated protein tau), among the first microtubule associated proteins to be identified, was implicated in microtubule initiation as well as assembly, with increased expression in neurons and specific association with axonal microtubules. Alzheimer's disease (AD) is the most prevalent tauopathy, exhibiting tau-neurofibrillary tangles associated with cognitive dysfunction. AD is also characterized by β-amyloid plaques. An abundance of tau inclusions, in the absence of β-amyloid deposits, can be found in Pick's disease, progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and other diseases, collectively described as tauopathies. The increase in tau pathology in AD correlates with the associated cognitive decline. The current manuscript touches on the variability as well as common denominators of the various tau pathologies coupled to new approaches/current innovation in treatment of tauopathies in favor of advanced technologies in predictive diagnostics, targeted preventive and personalized medicine (PPPM).
KW - Alzheimer's disease
KW - Frontotemporal dementia
KW - MAPT
KW - PPPM
KW - Tau
KW - Tauopathy
UR - http://www.scopus.com/inward/record.url?scp=79953064473&partnerID=8YFLogxK
U2 - 10.1007/s13167-010-0029-y
DO - 10.1007/s13167-010-0029-y
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 23199066
AN - SCOPUS:79953064473
SN - 1878-5077
VL - 1
SP - 305
EP - 316
JO - EPMA Journal
JF - EPMA Journal
IS - 2
ER -